Congenital intrahepatic portosystemic venous shunt presenting with paraparesis as the initial symptom.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Internal medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.52.0881PMID 24190148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of surgical splenorenal shunt-related hepatic myelopathy with endovascular interventional techniques.

  2012cited by this paper
• Transient ischemic attack: definition, diagnosis, and risk stratification.

  2011influential reference
• Hepatic encephalopathy therapy: An overview.

  2010cited by this paper
• Hepatic encephalopathy.

  2009cited by this paper
• RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia

  2009cited by this paper
• Congenital portal systemic encephalopathy misdiagnosed as senile dementia.

  2009cited by this paper
• Glutamine: A Trojan horse in ammonia neurotoxicity

  2006cited by this paper
• Incidence and clinical significance of spontaneous intrahepatic portosystemic venous shunts detected by sonography in adults without potential cause

  2006cited by this paper
• [Intrahepatic portosystemic venous shunt].

  2003cited by this paper
• Symptomatic intrahepatic portosystemic venous shunt: embolization with an alternative approach.

  2003cited by this paper
• The neurology of liver failure.

  2003cited by this paper
• Intrahepatic portosystemic venous shunt: diagnosis by colour/power Doppler imaging and three-dimensional ultrasound.

  2003cited by this paper
• Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?

  2001cited by this paper
• Hepatic encephalopathy

  2001cited by this paper
• Delayed myelopathic presentation of the acquired hepatocerebral degeneration syndrome

  2000cited by this paper
• The long-term prognosis of congenital portosystemic venous shunt.

  1999cited by this paper
• Ammonia and GABA‐ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy

  1997cited by this paper
• Case report: Portal‐systemic encephalopathy due to a congenital extrahepatic portosystemic shunt

  1996cited by this paper
• Reversible periodic alternating gaze deviation in hepatic encephalopathy

  1995cited by this paper
• Hepatic myelopathy: an unusual neurological complication of advanced hepatic disease.

  1994cited by this paper
• Hepatic encephalopathy mimicking stroke. A case report.

  1992cited by this paper
• Intrahepatic portosystemic venous shunt.

  1990cited by this paper
• PORTAL-SYSTEMIC ENCEPHALOPATHY DUE TO CONGENITAL INTRAHEPATIC SHUNTS.

  1964cited by this paper
• Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy.

  1960cited by this paper

• Morphometry, variations, and histogenesis of umbilical vein, portal sinus, and ductus venosus in human fetal liver: an anatomical study

  2024cites this paper
• Clinical findings, diagnosis and therapy of patent ductus venosus in children: a case series

  2022cites this paper
• Presentation of Congenital Portosystemic Shunts in Children

  2022cites this paper
• The Clinical and Imaging Findings of Patent Ductus Venosus in Children: A Series of Nine Cases

  2021cites this paper
• The Clinical and Imaging Findings of Patent Ductus Venosus in Children: A Retrospective Analysis

  2021cites this paper
• Laparoscopic Intervention after Ventriculoperitoneal Shunt: A Case Report, Systematic Review, and Recommendations

  2020cites this paper
• A case report of Spontaneous Intrahepatic Portosystemic Venous Shunt

  2020cites this paper
• Congenital portosystemic shunts: diagnosis and treatment

  2018cites this paper
• Congenital portosystemic venous shunt

  2017cites this paper
• Liver resection for the treatment of a congenital intrahepatic portosystemic venous shunt.

  2016cites this paper
• Evaluation of mid- and long-term efficacy of shunt limiting for hepatic myelopathy after transjugular intrahepatic portosystemic shunt.

  2016cites this paper